r/biotech
AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’
- upvotes
- 49
- comments
- 14
Extracted from these lines
[comment u/Plenty_of_prepotente] Livmoniplimab, the phase 2 solid tumor drug in the article, was being tested in combination with AbbVie's anti-PD-1 budigalimab, even though as a single agent livmo had an overall response rate in phase 1 of 0%.